[1]BorderWA , NobleNA .Mechanismsofdisease:transforminggrowthfactor -betaintissuefibrosis[J] NEnglJMed , 1994, 331∶12 86 .
|
[][2 ]张立煌 , 方海林 , 裘云庆 , 等 .病毒性肝炎患者血清转化生长因子 -β活性及其与肝纤维化的关系 [J] .中华传染病杂志 , 1997, 15∶82 .
|
[3]BedossaP , PeltierE , TerrisB , etal.Transforminggrowthfactor betal (TGF -β1 ) andTGF -β1 receptorinnormal, cirrhotic, andneoplastichumanlivers[J] Hepatology , 1995 , 2 1∶76 0 .
|
[4]RobertsAB , AnzanoMA , MeyersCA , etal.Purificationandprop ertiesofatypebetatransforminggrowthfactorfrombovinekidney[J] Biochemistry , 1983, 2 2∶5 6 92 .
|
[][5 ]TsaiJF , JengJE , ChuangLY , etal.Urinarytransforminggrowthfactorβ1 levelsinhepatitisCvirusrelatedchronicliverdiseas :cor relationbetweenhighlevelsandseverityofdisease[J] Hepatolo gy , 1997, 2 5∶114 1.
|
[1] | Yajie LIU, Ruilin WANG. Levels and clinical significance of urinary lead in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(9): 1771-1777. doi: 10.12449/JCH240909 |
[2] | Yan CHAI, Tao ZHANG, Yinke FAN, Aiwu HUI, Lintao ZHAO, Fang LI, Xiaoli ZHANG. Effect of Yangxue Rougan pills on the TGF-β1/Smad signaling pathway in a rat model of liver fibrosis induced by multiple factors[J]. Journal of Clinical Hepatology, 2022, 38(9): 2040-2045. doi: 10.3969/j.issn.1001-5256.2022.09.018 |
[3] | Wen QIN, Jianyu YANG, Taiwen CHEN, Haiping ZHENG, Xiaodong ZHU. Expression and significance of L1 cell adhesion molecule and transforming growth factor-β1 in pancreatic cancer tissue[J]. Journal of Clinical Hepatology, 2021, 37(6): 1404-1408. doi: 10.3969/j.issn.1001-5256.2021.06.035 |
[4] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
[5] | Mo XiaoLi, Liu Jie, Zhu JiaYu, Chen Chuang, Ou Jie, Mao SuFei. Value of transforming growth factor-β1 in diagnosis of primary liver cancer:a meta-analysis[J]. Journal of Clinical Hepatology, 2017, 33(5): 864-868. doi: 10.3969/j.issn.1001-5256.2017.05.014 |
[6] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
[7] | Feng Jie, Tang ZhengHao, Yu YongSheng. Expression of transcription factor Sp1 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(1): 65-67. |
[8] | Zheng SuJun, Xing XinYue, Wu JuShan, Wang ShiMei, Zhang Ying, Han YuanPing, Yu Hao, Chen Yu, Liu Mei, Duan ZhongPing. ShRNA targeted to rat Smad3 decreases the profibrosis role of TGFβ1 in HSC-T6 cells[J]. Journal of Clinical Hepatology, 2012, 28(4): 289-295. |
[9] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
[10] | Li YaPing, Dang ShuangSuo, Zhai Song, Jia XiaoLi, Wang Yuan, Wang XiuFang, Wang WenJun, Li Mei. Immunohistochemical expression of NF-κB, α-SMA and TGFβ1 in experimental hepatic injury rats[J]. Journal of Clinical Hepatology, 2011, 27(11): 1207-1210. |
[11] | Lu ZhongHua, Deng Jun, Yang XiaoJuan, Pei Hao, Zhuang LinNi, Chen Wei. TNF α and TGF β1 in the serum of patients with primary hepatic cancer before and after transcatheter arterial chemoembolization[J]. Journal of Clinical Hepatology, 2009, 25(6): 435-436. |
[12] | Kang HaiYan, Dong JiangLong, Ye LiHong, Wang JianBin, Liu Lian, Yin ShuYing. Relationship between the expression of BFGF/TGF-β1 in liver tissue and liver fibrosis/inflammation in 260 patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 97-99. |
[14] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
[15] | Liao Dan, Jiang JianNing, Luo GuangHan, Wu JiZhou. The expression and significance of TGF-β1 and smad4m RNA in chronic viral hepatitis and cirrhosis[J]. Journal of Clinical Hepatology, 2005, 21(2): 89-91. |
[16] | Xu TingTing, Jiang MiaoNa, Jia YuJie, Che Ying. Ganfukang's effect on transforming growth factor β1 and laminin of experimental liver fibrosis rats[J]. Journal of Clinical Hepatology, 2005, 21(1): 30-31. |
[17] | Ling YunFeng, Feng ZhenBo, He RuKun, Lu: ZiLi. Expression of TGFβ1、TGFβRⅠ and TGFβRⅡ in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2005, 21(1): 35-37. |
[19] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
[20] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |